2019—2021年安徽省合肥市某三甲医院住院的严重急性呼吸道感染患者的监测分析

Surveillance and analysis of inpatient severe acute respiratory infection in a top three hospital in Hefei City of Hefei Province from 2019 to 2021

  • 摘要:
    目的 分析2019—2021年在安徽省合肥市第二人民医院住院的严重急性呼吸道感染(SARI)患者的监测结果。
    方法 筛查2019年1月—2021年12月安徽省合肥市第二人民医院住院部监测科室(呼吸内科、儿内科与重症监护科)SARI患者的资料,并采集患者鼻咽拭子、呼吸道分泌物,通过反转录聚合酶链反应(RT-PCR)检测甲乙通用性流感病毒。
    结果 2019—2021年,共监测SARI患者934例,占监测科室同期入院病例的12.04%;2019年、2020年和2021年,SARI患者分别占入院患者的10.62%、14.90%和11.40%。2020年,检测出的SARI患者占比较高。2019—2021年,SARI监测病例主要集中于冬春季节,以5岁以下儿童病例占比较大(54.82%),男女比例为1.66∶1。SARI的监测科室分别为儿内科(82.12%)、呼吸内科(17.77%)以及重症监护科(0.11%);2019—2021年采集的934份咽拭子标本经实验室检测,阳性标本39份,阳性率为4.17%,主要感染病毒类型为B型Victoria系27例(69.23%)。SARI与流感阳性感染患者中合并症最常见的为肺炎,SARI合并并发症的467例患者中,99.36%的患者转归为治愈或好转,不合并并发症的患者中,99.57%的患者转归为治愈或好转,差异无统计学意义(P=1.000)。SARI病例采样前最常用的药物为抗生素与神经氨酸酶抑制剂类抗病毒药物。SARI病例中,使用抗病毒药物的患者中有98.66%疾病转归为治愈或好转,而不使用抗病毒药物的患者中,99.53%的患者疾病转归为治愈或好转,差异无统计学意义(P=0.343)。
    结论 2019—2021年,在安徽省合肥市第二人民医院住院的SARI病例多为男性、儿童、老人,冬春季为高发季节,流感阳性患者主要感染菌株均为FluB,且所有患者转归情况较好。

     

    Abstract:
    Objective To analyze the monitoring results of severe acute respiratory tract (SARI) cases hospitalized in the Second Hospital in Hefei City of Hefei Province from 2019 to 2021.
    Methods Data of SARI patients from the respiratory, pediatric and intensive care departments in the inpatient department of the Second Hospital in Hefei City of Anhui Province from January 2019 to December 2021 were screened. Nasopharyngeal swabs, respiratory secretions of patients were collected to detect universal influenza virus A and B by reverse transcription polymerase chain reaction (RT-PCR).
    Results From 2019 to 2021, a total of 934 SARI cases were monitored, accounting for 12.04% of the hospitalized cases in the same period in the monitoring department. The proportion of SARI in hospitalized cases was 10.62% in 2019, 14.90% in 2020 and 11.40% in 2021, respectively. In 2020, SARI patients accounted for a higher proportion. From 2019 to 2021, SARI cases were mainly concentrated in winter and spring, with children under 5 years of age, accounting for a large proportion (54.82%), with a male to female ratio of 1.66:1. The monitoring departments of SARI were department of pediatrics (82.12%), department of respiratory medicine (17.77%) and department of intensive care (0.11%). A total of 934 throat swab samples collected from 2019 to 2021 were tested in the laboratory, and 39 were positive, with a positive rate of 4.17%, the main type was type B Victoria system in 27 cases (69.23%). Pneumonia was the most common complication in SARI cases and positive infection patients. 99.36% of the 467 SARI patients with complications were cured or improved, while 99.57% of the patients without complications were cured or improved, showing no statistical difference between the two groups (P=1.000). The most common used drugs before sampling of SARI cases were antibiotics and neuraminidase inhibitors. In SARI cases, 98.66% of the patients who used antiviral drugs were cured or improved, while 99.53% of the patients who did not use antiviral drugs were cured or improved, which showed no statistical difference between the two groups (P=0.343).
    Conclusion From 2019 to 2021, most of the SARS cases hospitalized in the Second Hospital Hefei City of Anhui Province are men, children and the elderly, and it has a high incidence in winter and spring. The main influenza strains are FluB in positive patients, and all patients have good prognosis.

     

/

返回文章
返回